Kane JM, Petrelli NJ: Controversies in the surgical management of rectal cancer. Semin Radiat Oncol. 2003, 13: 403-418. 10.1016/j.semradonc.2003.07.001.
Article
PubMed
Google Scholar
Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001, 345: 638-646. 10.1056/NEJMoa010580.
Article
CAS
PubMed
Google Scholar
Colorectal Cancer Collaborative Group: Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet. 2001, 358: 1291-1304. 10.1016/S0140-6736(01)06409-1.
Article
Google Scholar
Wiggenraad R, Tamminga R, Blok P, Rouse R, Hermans J: The prognostic significance of p53 expression for survival and local control in rectal carcinoma treated with surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 1998, 41: 29-35. 10.1016/S0360-3016(98)00043-1.
Article
CAS
PubMed
Google Scholar
Lopez-Crapez E, Ychou M, Thèzenas S, Simony-Lafontaine J, Thirion A, Azria D, Bibeau F, Grenier J, Senesse P: P53 status and response to radiotherapy in rectal cancer : a prospective multilevel analysis. B J Cancer. 2005, 92 (12): 2114-2121. 10.1038/sj.bjc.6602622.
Article
CAS
Google Scholar
Tannapfel A, Nusslein S, Fietkau R, Katalinic A, Kockerling F, Wittekind C: Apoptosis, proliferation, bax, bcl-2 and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 1998, 41: 585-591. 10.1016/S0360-3016(98)00076-5.
Article
CAS
PubMed
Google Scholar
International Commission on Radiation Units and Measurements (ICRU): Prescribing, recording, and reporting photon beam therapy. ICRU report 62. 2001, Bethesda, Maryland
Google Scholar
Sobin L, Wittekind C, UICC eds: TNM Classification of Malignant Tumours. 1997, New York: Wiley-Liss
Google Scholar
Alroy I, Yarden Y: The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett. 1997, 410: 83-86. 10.1016/S0014-5793(97)00412-2.
Article
CAS
PubMed
Google Scholar
Hudziak RM, Schlessinger J, Ullrich A: Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells. Proc Natl Acad Sci U S A. 1987, 84: 7159-7163.
Article
CAS
PubMed
PubMed Central
Google Scholar
Allred DC, Clark GM, Molina R, Tandon AK, Schnitt SJ, Gilchrist KW, Osborne CK, Tormey DC, McGuire WL: Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum Pathol. 1992, 23: 974-979. 10.1016/0046-8177(92)90257-4.
Article
CAS
PubMed
Google Scholar
Schmidt-Ullrich RK, Dent P, Grant S, Mikkelsen RB, Valerie K: Signal transduction and cellular radiation responses. Radiat Res. 2000, 153: 245-257.
Article
CAS
PubMed
Google Scholar
Wollman R, Yahalom J, Maxy R, Pinto J, Fuks Z: Effect of epidermal growth factor on the growth and radiation sensitivity of human breast cancer cells in vitro. Int J Radiat Oncol Biol Phys. 1994, 30: 91-98.
Article
CAS
PubMed
Google Scholar
Gupta AK, McKenna WG, Weber CN, Feldman MD, Goldsmith JD, Mick R, Machtay M, Rosenthal DI, Bakanauskas VJ, Cerniglia GJ, Bernhard EJ, Weber RS, Muschel RJ: Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction. Clin Cancer Res. 2002, 8: 885-892.
PubMed
Google Scholar
Barker FG, Simmons ML, Chang SM, Prados MD, Larson DA, Sneed PK, Wara WM, Berger MS, Chen P, Israel MA, Aldape KD: EGFR overexpression and radiation response in glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2001, 51: 410-418. 10.1016/S0360-3016(01)01609-1.
Article
CAS
PubMed
Google Scholar
Balaban N, Moni J, Shannon M, Dang L, Murphy E, Goldkorn T: The effect of ionizing radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiation. Biochim Biophys Acta. 1996, 1314: 147-156. 10.1016/S0167-4889(96)00068-7.
Article
CAS
PubMed
Google Scholar
Schmidt-Ullrich RK, Mikkelsen RB, Dent P, Todd DG, Valerie K, Kavanagh BD, Contessa JN, Rorrer WK, Chen PB: Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene. 1997, 15: 1191-1197. 10.1038/sj.onc.1201275.
Article
CAS
PubMed
Google Scholar
Carter S, Auer KL, Reardon DB, Birrer M, Fisher PB, Valerie K, Schmidt-Ullrich R, Mikkelsen R, Dent P: Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells. Oncogene. 1998, 16: 2787-2796. 10.1038/sj.onc.1201802.
Article
CAS
PubMed
Google Scholar
Kavanagh BD, Dent P, Schmidt-Ullrich RK, Chen P, Mikkelsen RB: Calcium-dependent stimulation of mitogen-activated protein kinase activity in A431 cells by low doses of ionizing radiation. Radiat Res. 1998, 149: 579-587.
Article
CAS
PubMed
Google Scholar
Goldkorn T, Balaban N, Shannon M, Matsukuma K: EGF receptor phosphorylation is affected by ionizing radiation. Biochim Biophys Acta. 1997, 1358: 289-299. 10.1016/S0167-4889(97)00063-3.
Article
CAS
PubMed
Google Scholar
Dent P, Reardon DB, Park JS, Bowers G, Logsdon C, Valerie K, Schmidt-Ullrich R: Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death. Mol Biol Cell. 1999, 10: 2493-2506.
Article
CAS
PubMed
PubMed Central
Google Scholar
David M, Wong L, Flavell R, Thompson SA, Wells A, Larner AC, Johnson GR: STAT activation by epidermal growth factor (EGF) and amphiregulin. Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1. J Biol Chem. 1996, 271: 9185-9188. 10.1074/jbc.271.8.4134.
Article
CAS
PubMed
Google Scholar
Grandis JR, Drenning SD, Zeng Q, Watkins SC, Melhem MF, Endo S, Johnson DE, Huang L, He Y, Kim JD: Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci U S A. 2000, 97: 4227-4232. 10.1073/pnas.97.8.4227.
Article
CAS
PubMed
PubMed Central
Google Scholar
Park OK, Schaefer TS, Nathans D: In vitro activation of Stat3 by epidermal growth factor receptor kinase. Proc Natl Acad Sci U S A. 1996, 93: 13704-13708. 10.1073/pnas.93.24.13704.
Article
CAS
PubMed
PubMed Central
Google Scholar
Akimoto T, Hunter NR, Buchmiller L, Mason K, Kian Ang K, Milas L: Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas. Clin Cancer Res. 1999, 5: 2884-2890.
CAS
PubMed
Google Scholar
Sheridan MT, O'Dwyer T, Seymour CB, Mothersill CE: Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck. Radiat Oncol Investig. 1997, 5: 180-186. 10.1002/(SICI)1520-6823(1997)5:4<180::AID-ROI3>3.0.CO;2-U.
Article
CAS
PubMed
Google Scholar
Christensen ME, Therkildsen MH, Poulsen SS, Bretlau P: Immunoreactive transforming growth factor alpha and epidermal growth factor in oral squamous cell carcinomas. J Pathol. 1993, 169: 323-328. 10.1002/path.1711690308.
Article
CAS
PubMed
Google Scholar
Dassonville O, Formento JL, Francoual M, Ramaioli A, Santini J, Schneider M, Demard F, Milano G: Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Clin Oncol. 1993, 11: 1873-1878.
CAS
PubMed
Google Scholar
Grandis JR, Tweardy DJ: TGF-alpha and EGFR in head and neck cancer. J Cell Biochem. 1993, 17F (Suppl): 188-191. 10.1002/jcb.240531027.
Article
CAS
Google Scholar
Lee CS, Redshaw A, Boag G: Epidermal growth factor receptor immunoreactivity in human laryngeal squamous cell carcinoma. Pathology. 1997, 29: 251-254.
Article
CAS
PubMed
Google Scholar
Maiorano E, Favia G, Maisonneuve P, Viale G: Prognostic implications of epidermal growth factor receptor immunoreactivity in squamous cell carcinoma of the oral mucosa. J Pathol. 1998, 185: 167-174. 10.1002/(SICI)1096-9896(199806)185:2<167::AID-PATH70>3.0.CO;2-E.
Article
CAS
PubMed
Google Scholar
Santini J, Formento JL, Francoual M, Milano G, Schneider M, Dassonville O, Demard F: Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck. 1991, 13: 132-139.
Article
CAS
PubMed
Google Scholar
Etienne MC, Pivot X, Formento JL, Bensadoun RJ, Formento P, Dassonville O, Francoual M, Poissonnet G, Fontana X, Schneider M, Demard F, Milano G: A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil. Br J Cancer. 1999, 79: 1864-1869. 10.1038/sj.bjc.6690297.
Article
CAS
PubMed
PubMed Central
Google Scholar
Miyaguchi M, Olofsson J, Hellquist HB: Expression of epidermal growth factor receptor in glottic carcinoma and its relation to recurrence after radiotherapy. Clin Otolaryngol. 1991, 16: 466-469.
Article
CAS
PubMed
Google Scholar
Wen QH, Miwa T, Yoshizaki T, Nagayama I, Furukawa M, Nishijima H: Prognostic value of EGFR and TGF-alpha in early laryngeal cancer treated with radiotherapy. Laryngoscope. 1996, 106: 884-888. 10.1097/00005537-199607000-00019.
Article
CAS
PubMed
Google Scholar
Almadori G, Cadoni G, Galli J, Ferrandina G, Scambia G, Exarchakos G, Paludetti G, Ottaviani F: Epidermal growth factor receptor expression in primary laryngeal cancer: an independent prognostic factor of neck node relapse. Int J Cancer. 1999, 84: 188-191. 10.1002/(SICI)1097-0215(19990420)84:2<188::AID-IJC16>3.0.CO;2-1.
Article
CAS
PubMed
Google Scholar
Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, Fu KK, Milas L: Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res. 2002, 62: 7350-7356.
CAS
PubMed
Google Scholar
Magne N, Pivot X, Bensadoun RJ, Guardiola E, Poissonnet G, Dassonville O, Francoual M, Formento JL, Demard F, Schneider M, Milano G: The relationship of epidermal growth factor receptor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo- radiotherapy. Eur J Cancer. 2001, 37: 2169-2177. 10.1016/S0959-8049(01)00280-5.
Article
CAS
PubMed
Google Scholar
Chua DT, Nicholls JM, Sham JS, Au GK: Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys. 2004, 59: 11-20. 10.1016/j.ijrobp.2003.10.038.
Article
CAS
PubMed
Google Scholar
Steele RJ, Kelly P, Ellul B, Eremin O: Epidermal growth factor receptor expression in colorectal cancer. Br J Surg. 1990, 77: 1352-1354.
Article
CAS
PubMed
Google Scholar
Mayer A, Takimoto M, Fritz E, Schellander G, Kofler K, Ludwig H: The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer. 1993, 71: 2454-2460.
Article
CAS
PubMed
Google Scholar
Giralt J, Eraso A, Armengol M, Rossello J, Majo J, Ares C, Espin E, Benavente S, de Torres I: Epidermal growth factor receptor is a predictor of tumor response in locally advanced rectal cancer patients treated with preoperative radiotherapy. Int J Radiat Oncol Biol Phys. 2002, 54: 1460-1465. 10.1016/S0360-3016(02)03752-5.
Article
CAS
PubMed
Google Scholar
Dworak O, Keilholz L, Hoffmann A: Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997, 12: 19-23. 10.1007/s003840050072.
Article
CAS
PubMed
Google Scholar
Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, Chau I, van Custem E: Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med. 2004, 351: 337-345. 10.1056/NEJMoa033025.
Article
CAS
PubMed
Google Scholar
Galandiuk S, Wieand HS, Moertel CG, Cha SS, Fitzgibbons RJ, Pemberton JH, Wolff BG: Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet. 1992, 174: 27-32.
CAS
PubMed
Google Scholar
Obrand DI, Gordon PH: Incidence and patterns of recurrence following curative resection for colorectal carcinoma. Dis Colon Rectum. 1997, 40: 15-24.
Article
CAS
PubMed
Google Scholar
Konn M, Morita T, Hada R, Yamanaka Y, Sasaki M, Munakata H, Suzuki H, Inoue S, Endoh M, Sugiyama Y: Survival and recurrence after low anterior resection and abdominoperineal resection for rectal cancer: the results of a long-term study with a review of the literature. Surg Today. 1993, 23: 21-30. 10.1007/BF00308995.
Article
CAS
PubMed
Google Scholar
Michelassi F, Vannucci L, Ayala JJ, Chappel R, Goldberg R, Block GE: Local recurrence after curative resection of colorectal adenocarcinoma. Surgery. 1990, 108: 787-792.
CAS
PubMed
Google Scholar
Arbman G, Nilsson E, Hallbook O, Sjodahl R: Local recurrence following total mesorectal excision for rectal cancer. Br J Surg. 1996, 83: 375-379.
Article
CAS
PubMed
Google Scholar
de Haas-Kock DF, Baeten CG, Jager JJ, Langendijk JA, Schouten LJ, Volovics A, Arends JW: Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg. 1996, 83: 781-785.
Article
CAS
PubMed
Google Scholar
Bjerkeset T, Edna TH: Rectal cancer: the influence of type of operation on local recurrence and survival. Eur J Surg. 1996, 162: 643-648.
CAS
PubMed
Google Scholar
Azria D, Larbouret C, Robert B, Culine S, Ychou M, Verrelle P, Dubois JB, Pelegrin A: Anti-EGF receptors and radiation therapy: current translational research and early clinical trials. Bull Cancer. 2003, 90: 202-212.
Google Scholar
Sartor CI: Epidermal growth factor family receptors and inhibitors: radiation response modulators. Semin Radiat Oncol. 2003, 13: 22-30. 10.1053/srao.2003.50003.
Article
PubMed
Google Scholar